• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AMGA Statement on 2022 Medicare Advantage Advance Notice

Article

AMGA recommended that the Centers for Medicare & Medicaid Services (CMS) finalize a number of its proposed policies for the Medicare Advantage program.

Alexandria, VA – AMGA today recommended that the Centers for Medicare & Medicaid Services (CMS) finalize a number of its proposed policies for the Medicare Advantage program. AMGA and its members are strong supporters of the MA program, which offers a financing mechanism and benefit package that helps support care coordination.

AMGA also recommended that CMS continue to recognize the effect of COVID-19 and ensure that audio-only visits remain available for providers and their patients. CMS should allow audio-only telephone calls to satisfy the face-to-face requirement for collecting diagnosis information for risk adjustment purposes.

Read the full press release here.

Related Videos
AMCP Recap 2025
Andrew Evens, DO
Screenshot from interview with Andrew Evens, DO
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center
Andrew Kuykendall, MD, Moffitt Cancer Center
Joshua Kaufman, MD, CDPHP
Cathy Eng, MD, FACP, FASCO
Andrew Kuykendall, MD, Moffitt Cancer Center
Frederick L. Locke, MD, Moffitt Cancer Center and Research Institute
Jorge García, PharmD, MS, MBA, MHA, FACHE, FACCC
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.